𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial

✍ Scribed by Afshar, H; Roohafza, H; Mousavi, G; Golchin, S; Toghianifar, N; Sadeghi, M; Talaei, M

Book ID
126917848
Publisher
SAGE Publications
Year
2008
Tongue
English
Weight
316 KB
Volume
23
Category
Article
ISSN
0269-8811

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mirtazapine add-on therapy in the treatm
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial
✍ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti

A randomised double-blind placebo-contro
A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
✍ P. Loiseau; A.W.C. Yuen; B. DuchΓ©; T. MΓ©nager; M.C. ArnΓ©-BΓ¨s πŸ“‚ Article πŸ“… 1990 πŸ› Elsevier Science 🌐 English βš– 874 KB

Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure